Soft β-adrenergic agonists for the topical treatment of psoriasis

European Journal of Medicinal Chemistry

Volumn 31, Issue 11, 1996, Pages 847-859

  Gill, H S ^a,c   Freeman, S ^a,b   Irwin, W J ^a   Wilson, K A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Pro drug; Psoriasis; Soft drug; Transport; adrenergic agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PRODRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG METABOLISM; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; GUINEA PIG; HYDROLYSIS; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PKA; PSORIASIS; REACTION ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SMOOTH MUSCLE CONTRACTION; TRACHEA;

EID: 0029801531     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)89848-0     Document Type: Article

References (45)

1. 1 Roenigk HH, Maibach HI (1991) Psoriasis 2nd ed, Marcel Dekker, New York
2. 2 Voorhees JJ, Marcelo CL, Duell EA (1975) J Invest Dermatol 65, 179-190
3. 3 Voorhees JJ, Duell EA (1971) Arch Dermatol 104, 352-358
4. 4 Voorhees JJ, Stawiski M, Duell EA (1973) Life Sciences 13, 639-653
5. 5 Marks F, Rebein W (1972) Naturwissenschaften 59, 41-42
6. 6 Voorhees J, Duell E, Kelsey W (1972) Arch Dermatol 105, 384-386
7. 7 Duell EA, Voorhees JJ (1983) In: Biochemistry and Physiology of the Skin (Goldsmith LA, ed) Oxford University Press, New York, 241-268
8. 8 Main BG (1990) In: Comprehensive Medicinal Chemistry (Sammes PG, Taylor JB, eds) volume 3, 187-228
9. 9 Das NS, Chowdary TN, Sobhanadri C, Rao KV (1978) Br J Dermatol 99, 197-200
10. 10 Seely RJ, Glenn EM (1978) Proc Soc Exp Biol Med 159, 223-225
11. 11 Green KL, Sapra M (1985) J Pharm Pharmacol 37, 502P
12. 12 Powell JA, Duell EA, Voorhees JJ (1971) Arch Dermatol 104, 359-365
13. 13 Gaylarde PM, Brock AP, Sarkany I (1978) Clin Exp Dermatol 3, 157-160
14. 14 Wiley HE, Weinstein GD (1979) J Invest Dermatol 73, 545-547
15. 15 Rusin LJ, Duell EA, Voorhees JJ (1978) J Invest Dermatol 71, 154-156
16. 16 Bilski AJ, Evans JR, Harrison MP et al (1986) Biochem Soc Trans 14, 388-391
17. 17 Irwin WJ, Belaid KA (1987) Drug Develop Ind Pharm 13, 2017-2031
18. 18 Bodor N (1984) Adv Drug Res 13, 255-331
19. 19 Bundgaard H (1985) Design of Prodrugs, Elsevier, Amsterdam
20. 20 Krogsgaard-Larsen P, Bundgaard H (1991) A Textbook of Drug Design and Development, Harwood Academic, Oxford, 113-191
21. 21 Wei CP, Andersen JA, Leopold I (1978) Invest Ophthalmol Vis Sci 17, 315-321
22. 22 Anderson JA, Richman JB, Mindel JS (1984) Arch Ophthalmol 102, 913-916
23. 23 Mindel JS, Cohen G, Barker LA, Lewis DE (1984) Arch Ophthalmol 102, 457-460
24. 24 Remizov AL (1958) Zhur Obshchei Khim 28, 2530-2538
25. 25 Powell WS, Heacock RA, Smith DG, McInnes AG (1973) Can J Chem 51, 776-779
26. 26 Carstensen JT (1995) Drug Stability: Principles and Practices 2nd ed, Marcel Dekker, New York, 59-121
27. 27 Irwin WJ (1990) Kinetics of Drug Decomposition: BASIC Computer Solutions Elsevier, Amsterdam, 175-181
28. a Prediction for Organic Acids and Bases Chapman and Hall, London, 27-43
29. 29 Irwin WJ, Belaid KA (1987) Drug Develop Ind Pharm 13, 2033-2045
30. 30 Albert A, Serjeant EP (1984) The Determination of Ionisation Constants: A Laboratory Manual 3rd ed, Chapman and Hall, London, 148
31. 31 Wall GM, Kenny JC, Fan TY et al (1992) J Pharm Biomed Anal 10, 465-471
32. 32 Ihara M, Nakajima S, Hisaka A et al (1990) J Pharm Sci 79, 703-708
33. 33 Fuller EJ (1963) J Am Chem Soc 85, 1777-1780
34. 34 Hansen B (1963) Acta Chem Scand 17, 1375-1379
35. 35 Guy RH, Maibach HI, Shah VP (1986) Pharm Res 3, 253-262
36. 36 Hadgraft J (1989) In: Pharmacology and the Skin, Vol 2. Nonsteroidal Anti-inflammatory Drugs (Hensby C, Lowe NJ eds) Karger, Basel, 21-43
37. 37 Houk J, Guy RH (1988) Chem Rev 88, 455-471
38. 38 Nacht S, Yeung D (1985) In: Percutaneous Absorption. Mechanisms-Methodology-Drug Delivery (Bronaugh RL, Maibach HI, eds) Marcel Dekker, New York, 373-386
39. 39 Barry BW (ed) (1983) Dermatological Formulations: Percutaneous Absorption 18, Marcel Dekker, New York, 72
40. 40 Krebs EG (1989) JAMA 262, 1815-1818
41. 41 Constantine JW (1965) J Pharm Pharmacol 17, 384-385
42. 42 O'Donnel SR, Dunstall JC (1974) Br J Pharmacol 52, 407-417
43. 43 Albert A, Serjeant EP (1984) The Determination of Ionization Constants. A Laboratory Manual Chapman and Hall, London, 3rd ed
44. 44 Elving PJ, Markowitz JM, Rosenthal I (1956) Anal Chem 28, 1179-1180
45. 45 Fife TH, Bruice TC (1961) J Phys Chem 65, 1079-1080